532 related articles for article (PubMed ID: 22147895)
1. Loss-of-function germline GATA2 mutations in patients with MDS/AML or MonoMAC syndrome and primary lymphedema reveal a key role for GATA2 in the lymphatic vasculature.
Kazenwadel J; Secker GA; Liu YJ; Rosenfeld JA; Wildin RS; Cuellar-Rodriguez J; Hsu AP; Dyack S; Fernandez CV; Chong CE; Babic M; Bardy PG; Shimamura A; Zhang MY; Walsh T; Holland SM; Hickstein DD; Horwitz MS; Hahn CN; Scott HS; Harvey NL
Blood; 2012 Feb; 119(5):1283-91. PubMed ID: 22147895
[TBL] [Abstract][Full Text] [Related]
2. GATA2 is required for lymphatic vessel valve development and maintenance.
Kazenwadel J; Betterman KL; Chong CE; Stokes PH; Lee YK; Secker GA; Agalarov Y; Demir CS; Lawrence DM; Sutton DL; Tabruyn SP; Miura N; Salminen M; Petrova TV; Matthews JM; Hahn CN; Scott HS; Harvey NL
J Clin Invest; 2015 Aug; 125(8):2979-94. PubMed ID: 26214525
[TBL] [Abstract][Full Text] [Related]
3. GATA2 mutations lead to MDS and AML.
Hyde RK; Liu PP
Nat Genet; 2011 Sep; 43(10):926-7. PubMed ID: 21956389
[No Abstract] [Full Text] [Related]
4. High frequency of GATA2 mutations in patients with mild chronic neutropenia evolving to MonoMac syndrome, myelodysplasia, and acute myeloid leukemia.
Pasquet M; Bellanné-Chantelot C; Tavitian S; Prade N; Beaupain B; Larochelle O; Petit A; Rohrlich P; Ferrand C; Van Den Neste E; Poirel HA; Lamy T; Ouachée-Chardin M; Mansat-De Mas V; Corre J; Récher C; Plat G; Bachelerie F; Donadieu J; Delabesse E
Blood; 2013 Jan; 121(5):822-9. PubMed ID: 23223431
[TBL] [Abstract][Full Text] [Related]
5. Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome).
Ostergaard P; Simpson MA; Connell FC; Steward CG; Brice G; Woollard WJ; Dafou D; Kilo T; Smithson S; Lunt P; Murday VA; Hodgson S; Keenan R; Pilz DT; Martinez-Corral I; Makinen T; Mortimer PS; Jeffery S; Trembath RC; Mansour S
Nat Genet; 2011 Sep; 43(10):929-31. PubMed ID: 21892158
[TBL] [Abstract][Full Text] [Related]
6. GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity.
Spinner MA; Sanchez LA; Hsu AP; Shaw PA; Zerbe CS; Calvo KR; Arthur DC; Gu W; Gould CM; Brewer CC; Cowen EW; Freeman AF; Olivier KN; Uzel G; Zelazny AM; Daub JR; Spalding CD; Claypool RJ; Giri NK; Alter BP; Mace EM; Orange JS; Cuellar-Rodriguez J; Hickstein DD; Holland SM
Blood; 2014 Feb; 123(6):809-21. PubMed ID: 24227816
[TBL] [Abstract][Full Text] [Related]
7. Heritable GATA2 mutations associated with familial AML-MDS: a case report and review of literature.
Gao J; Gentzler RD; Timms AE; Horwitz MS; Frankfurt O; Altman JK; Peterson LC
J Hematol Oncol; 2014 Apr; 7():36. PubMed ID: 24754962
[TBL] [Abstract][Full Text] [Related]
8. A novel germline GATA2 frameshift mutation with a premature stop codon in a family with congenital sensory hearing loss and myelodysplastic syndrome.
Nakazawa H; Yamaguchi T; Sakai H; Maruyama M; Kawakami T; Kawakami F; Nishina S; Ishikawa M; Kosho T; Ishida F
Int J Hematol; 2021 Aug; 114(2):286-291. PubMed ID: 33759087
[TBL] [Abstract][Full Text] [Related]
9. MDS-associated mutations in germline GATA2 mutated patients with hematologic manifestations.
McReynolds LJ; Yang Y; Yuen Wong H; Tang J; Zhang Y; Mulé MP; Daub J; Palmer C; Foruraghi L; Liu Q; Zhu J; Wang W; West RR; Yohe ME; Hsu AP; Hickstein DD; Townsley DM; Holland SM; Calvo KR; Hourigan CS
Leuk Res; 2019 Jan; 76():70-75. PubMed ID: 30578959
[TBL] [Abstract][Full Text] [Related]
10. Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia.
Hahn CN; Chong CE; Carmichael CL; Wilkins EJ; Brautigan PJ; Li XC; Babic M; Lin M; Carmagnac A; Lee YK; Kok CH; Gagliardi L; Friend KL; Ekert PG; Butcher CM; Brown AL; Lewis ID; To LB; Timms AE; Storek J; Moore S; Altree M; Escher R; Bardy PG; Suthers GK; D'Andrea RJ; Horwitz MS; Scott HS
Nat Genet; 2011 Sep; 43(10):1012-7. PubMed ID: 21892162
[TBL] [Abstract][Full Text] [Related]
11. [Clinical and molecular characteristics of GATA2 related pediatric primary myelodysplastic syndrome].
An WB; Liu C; Wan Y; Chen XY; Guo Y; Chen XJ; Yang WY; Chen YM; Zhang YC; Zhu XF
Zhonghua Xue Ye Xue Za Zhi; 2019 Jun; 40(6):477-483. PubMed ID: 31340620
[No Abstract] [Full Text] [Related]
12. Comparison of Outcomes of Myeloablative Allogeneic Stem Cell Transplantation for Pediatric Patients with Bone Marrow Failure, Myelodysplastic Syndrome and Acute Myeloid Leukemia with and without Germline GATA2 Mutations.
Hofmann I; Avagyan S; Stetson A; Guo D; Al-Sayegh H; London WB; Lehmann L
Biol Blood Marrow Transplant; 2020 Jun; 26(6):1124-1130. PubMed ID: 32088370
[TBL] [Abstract][Full Text] [Related]
13. The evolution of cellular deficiency in GATA2 mutation.
Dickinson RE; Milne P; Jardine L; Zandi S; Swierczek SI; McGovern N; Cookson S; Ferozepurwalla Z; Langridge A; Pagan S; Gennery A; Heiskanen-Kosma T; Hämäläinen S; Seppänen M; Helbert M; Tholouli E; Gambineri E; Reykdal S; Gottfreðsson M; Thaventhiran JE; Morris E; Hirschfield G; Richter AG; Jolles S; Bacon CM; Hambleton S; Haniffa M; Bryceson Y; Allen C; Prchal JT; Dick JE; Bigley V; Collin M
Blood; 2014 Feb; 123(6):863-74. PubMed ID: 24345756
[TBL] [Abstract][Full Text] [Related]
14. Successful umbilical cord blood hematopoietic stem cell transplantation in pediatric patients with MDS/AML associated with underlying GATA2 mutations: two case reports and review of literature.
Mallhi K; Dix DB; Niederhoffer KY; Armstrong L; Rozmus J
Pediatr Transplant; 2016 Nov; 20(7):1004-1007. PubMed ID: 27416790
[TBL] [Abstract][Full Text] [Related]
15. Germ-line GATA2 p.THR354MET mutation in familial myelodysplastic syndrome with acquired monosomy 7 and ASXL1 mutation demonstrating rapid onset and poor survival.
Bödör C; Renneville A; Smith M; Charazac A; Iqbal S; Etancelin P; Cavenagh J; Barnett MJ; Kramarzová K; Krishnan B; Matolcsy A; Preudhomme C; Fitzgibbon J; Owen C
Haematologica; 2012 Jun; 97(6):890-4. PubMed ID: 22271902
[TBL] [Abstract][Full Text] [Related]
16. Prevalence, clinical characteristics, and prognosis of GATA2-related myelodysplastic syndromes in children and adolescents.
Wlodarski MW; Hirabayashi S; Pastor V; Starý J; Hasle H; Masetti R; Dworzak M; Schmugge M; van den Heuvel-Eibrink M; Ussowicz M; De Moerloose B; Catala A; Smith OP; Sedlacek P; Lankester AC; Zecca M; Bordon V; Matthes-Martin S; Abrahamsson J; Kühl JS; Sykora KW; Albert MH; Przychodzien B; Maciejewski JP; Schwarz S; Göhring G; Schlegelberger B; Cseh A; Noellke P; Yoshimi A; Locatelli F; Baumann I; Strahm B; Niemeyer CM;
Blood; 2016 Mar; 127(11):1387-97; quiz 1518. PubMed ID: 26702063
[TBL] [Abstract][Full Text] [Related]
17. Donor-derived MDS/AML in families with germline
Galera P; Hsu AP; Wang W; Droll S; Chen R; Schwartz JR; Klco JM; Arai S; Maese L; Zerbe C; Parta MJ; Young NS; Holland SM; Hickstein DD; Calvo KR
Blood; 2018 Nov; 132(18):1994-1998. PubMed ID: 30232126
[No Abstract] [Full Text] [Related]
18. Genetic predisposition syndromes: when should they be considered in the work-up of MDS?
Babushok DV; Bessler M
Best Pract Res Clin Haematol; 2015 Mar; 28(1):55-68. PubMed ID: 25659730
[TBL] [Abstract][Full Text] [Related]
19. Spectrum of myeloid neoplasms and immune deficiency associated with germline GATA2 mutations.
Mir MA; Kochuparambil ST; Abraham RS; Rodriguez V; Howard M; Hsu AP; Jackson AE; Holland SM; Patnaik MM
Cancer Med; 2015 Apr; 4(4):490-9. PubMed ID: 25619630
[TBL] [Abstract][Full Text] [Related]
20. Quantitative and qualitative impairments in GATA2 and myeloid neoplasms.
Shimizu R; Yamamoto M
IUBMB Life; 2020 Jan; 72(1):142-150. PubMed ID: 31675473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
